Comprehensive Study Notes: Systemic Hypertension

Introduction and Global Burden of Systemic Hypertension

• General Significance: Hypertension is recognized as one of the most common diseases affecting humans on a global scale.
• Mortality and Risk: It remains the leading cause of death worldwide. It is identified as the most critical modifiable risk factor for several severe conditions, including:
  • Coronary heart disease.
  • Stroke.
  • Congestive heart failure.
  • End-stage renal disease (ESRD).
  • Peripheral vascular disease.
• World Health Organization (WHO) Data: According to WHO data from the year $2000$, hypertension is a leading risk factor for attributable deaths globally, ranking among the most significant potentially preventable causes of mortality.

Definition and Diagnostic Standards

• Office Blood Pressure (BP): Hypertension is defined in a clinical or office setting when the systolic BP is equal to or greater than $140\,mmHg$ and/or the diastolic BP is equal to or greater than $90\,mmHg$.
• Out-of-office BP Monitoring: Home BP monitoring or ambulatory BP monitoring (if available) serves as an essential adjunct to conventional office measurements. This is primarily done to exclude "white coat" effects and assess normal BP levels away from a medical environment.
  • The cut-off value for home BP (or daytime ambulatory BP) is defined as $135/85\,mmHg$.
• Diagnosis Protocol: A clinical diagnosis of hypertension must be based on at least two separate BP measurements taken in the sitting position, during at least two separate visits, using a validated measurement device.

2018 ESC/ESH Classification of Office Blood Pressure

According to the recent guidelines from the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC), office BP is categorized as follows:

• Optimal: Systolic $< 120\,mmHg$ AND Diastolic $< 80\,mmHg$.
• Normal: Systolic $120-129\,mmHg$ AND/OR Diastolic $80-84\,mmHg$.
• High Normal: Systolic $130-139\,mmHg$ AND/OR Diastolic $85-89\,mmHg$.
• Grade 1 Hypertension: Systolic $140-159\,mmHg$ AND/OR Diastolic $90-99\,mmHg$.
• Grade 2 Hypertension: Systolic $160-179\,mmHg$ AND/OR Diastolic $100-109\,mmHg$.
• Grade 3 Hypertension: Systolic $\ge 180\,mmHg$ AND/OR Diastolic $\ge 110\,mmHg$.
• Isolated Systolic Hypertension: Systolic $\ge 140\,mmHg$ AND Diastolic $< 90\,mmHg$.

Etiology of Hypertension

Hypertension is broadly classified into two categories based on its cause: Primary (Essential) and Secondary.

• Primary (Essential) Hypertension:

  • Accounts for approximately $95\%$ of all diagnosed cases.
  • It is diagnosed in the absence of an identifiable specific cause and may develop due to complex genetic or environmental factors.
  • Onset typically occurs between the ages of $25$ and $55$ years; it is considered uncommon for primary hypertension to develop before the age of $20$.

• Precipitating Factors for Primary Hypertension:

  • Genetic Factors: Children of hypertensive parents have a higher predisposition.
  • Lifestyle: Obesity, lack of physical exercise, and heavy alcohol intake.
  • Diet: Excessive salt intake and low potassium intake.
  • Tobacco: Cigarette smoking.
  • Physiological/Medication Factors: Polycythemia, insulin resistance, and sympathetic over-activity.
  • NSAIDs: Non-steroidal anti-inflammatory drugs are noted to increase blood pressure by approximately $5\,mmHg$.

• Secondary Hypertension:

  • Accounts for approximately $5\%$ of cases where a specific underlying cause can be identified.
  • This type is frequently seen in younger patients. Causes include:
    1. Renal Parenchymal Disease ($2.5-6\%$): Including polycystic kidney disease, urinary tract obstruction, renin-producing tumors, and Liddle syndrome.
    2. Renovascular Hypertension ($0.2-4\%$): Renal artery stenosis, which commonly presents as fibromuscular dysplasia in young patients and atherosclerosis in elderly patients.
    3. Vascular Disorders: Coarctation of the aorta, vasculitis, and collagen vascular diseases.
    4. Endocrine Causes ($1-2\%$): Primary aldosteronism (Conn's syndrome), Cushing syndrome, pheochromocytoma, congenital adrenal hyperplasia, hyperthyroidism, hypothyroidism, hyperparathyroidism (leading to hypercalcemia), and acromegaly.
    5. Pregnancy-Induced Hypertension.
    6. Neurogenic Causes.
    7. Drugs and Toxins: Alcohol, cocaine, cyclosporine, erythropoietin, adrenergic medications, oral contraceptives (especially those containing estrogen), and NSAIDs.

Pathogenesis of Essential Hypertension

• Complexity: The exact mechanism remains unknown due to its highly complex, multifactorial nature.
• The Kidney's Role: The kidney acts as both a contributing organ and a target organ in the hypertensive process.
• Hemodynamic Formula: Hypertension is the persistent elevation of systemic BP, which is the product of Cardiac Output (CO) and Total Peripheral Vascular Resistance (TPVR):     BP = ext{Cardiac Output} \times ext{Total Peripheral Resistance}
• Short-term Regulation Factors: Tissue perfusion is managed by several factors including:
  • Circulatory blood volume.
  • Vascular caliber, elasticity, and reactivity.
  • Humoral mediators.
  • Neuronal stimulation.
• Long-term Pathogenic Drivers: Key drivers include genetics, activation of neurohormonal systems (Sympathetic Nervous System and Renin-Angiotensin-Aldosterone System), obesity, and high dietary salt intake.

Clinical Features and Physical Signs

• Symptoms:
  • Hypertension is mostly asymptomatic and often discovered during routine examinations or when complications arise.
  • Suboccipital Pulsating Headache: Characterized as occurring in the early morning and subsiding during the day.
  • Hypertensive Encephalopathy: May present with somnolence, confusion, visual disturbances, nausea, and vomiting.
  • Secondary Cause Symptoms: For example, pheochromocytoma may present with episodic hypertension, anxiety, palpitations, profuse perspiration (sweating), pallor, and tremors.
  • Complication Symptoms: Symptoms related to heart failure, stroke, or renal failure.
• Physical Signs:
  • Often, the only sign is elevated BP.
  • Underlying Causes: Abdominal bruits (renovascular obstruction) or delayed femoral pulses (coarctation of the aorta).
  • Hypertensive Heart Disease (Left Ventricular Hypertrophy): Prominent left ventricular apical heave and a loud aortic second heart sound ($S_2$).

Assessment and Cardiovascular Risk Stratification

• Assessment Goals: Identify secondary causes, assess disease progression, and evaluate comorbid conditions.
• Confirmation: Documentation requires elevated BP on at least $3$ separate occasions (based on the average of $2$ or more readings at each of $2$ or more follow-up visits).
• Target End-Organ Damage History:
  • Myocardial Infarction (MI), coronary revascularization, angina, heart failure, or LVH.
  • Stroke or Transient Ischemic Attack (TIA).
  • Chronic Kidney Disease (CKD), peripheral arterial disease, or retinopathy.
• CVD Risk Factors:
  • Family history of premature CVD (Men $< 55$ years; Women $< 65$ years).
  • Smoking, dyslipidemia (high LDL-C or low HDL-C), and diabetes mellitus (impaired fasting glucose or abnormal GTT).
  • Obesity ($BMI \ge 30\,kg/m^2$), lack of exercise, and age (Men $> 55$ years; Women $> 65$ years).
  • Micro-albuminuria.

10-Year CV Risk Categories (SCORE System)

• Very High Risk: Documented CVD (clinical or imaging showing $\ge 50\%$ stenosis), DM with target organ damage, severe CKD ($eGFR < 30\,mL/min/1.73\,m^2$), or a SCORE $\ge 10\%$.
• High Risk: Markedly elevated single risk factors (e.g., Cholesterol $> 8\,mmol/L$), Grade 3 HTN ($\ge 180/110\,mmHg$), Hypertensive LVH, moderate CKD ($eGFR\,30-59\,mL/min/1.73\,m^2$), or SCORE $5-10\%$.
• Moderate Risk: Grade 2 HTN, or SCORE $1-5\%$.
• Low Risk: SCORE $< 1\%$.

Diagnostic Procedures and Laboratory Work-up

• Basal Investigations (For all patients):
  • CBC: Hemoglobin/hematocrit to detect polycythemia or anemia.
  • Lipid Profile: Total, LDL-C, HDL-C, and Triglycerides.
  • Urine Analysis: Proteinuria and microalbuminuria.
  • ECG: Screening for Left Ventricular Hypertrophy (LVH).
  • FBG: Fasting Blood Glucose to screen for DM.
  • Serum Electrolytes: Sodium ($Na^+$) and Potassium ($K^+$). Low $K^+$ may suggest hyperaldosteronism.
  • Serum Uric Acid: Hyperuricemia is a relative contraindication for diuretic therapy.
  • Creatinine and eGFR: Assessing renal function.
• Additional/Follow-up Investigations:
  • Chest X-ray: To look for cardiomegaly or heart failure.
  • Echocardiography: For symptomatic heart failure patients.
  • Renovascular screening: Radioisotope scan, renal duplex ultrasound, and angiography.
  • Pheochromocytoma: $24$-hour urinary catecholamines or plasma-free metanephrine.
  • Cushing Syndrome: Overnight dexamethasone suppression test or $24$-hour urinary cortisol.
  • Coarctation: BP in legs, echocardiography, or MRI/CT angiography.

Treatment and Management of Hypertension

• Therapeutic Goals: Reduction of cardiovascular and renal morbidity/mortality.
  • General target: $< 140/90\,mmHg$.
  • Diabetes or Renal disease target: $< 130/80\,mmHg$.
  • Elderly ($> 65$ years): $140-150\,mmHg$ ($< 140\,mmHg$ if fit).
  • Elderly ($> 80$ years): $140-150\,mmHg$ if in good condition.
• Lifestyle Modifications:
  • Weight Reduction: Essential for BP control.
  • Exercise: $20-30$ minutes per day for at least $5$ days a week.
  • Diet: Low sodium ($2-3\,g$ or less), high in vegetables/fruits (potassium-rich), and low in saturated fats.
  • Habits: Smoking cessation and decreased alcohol intake.
• Pharmacologic Therapy:
  • Drug Classes: ACE Inhibitors (ACEI), Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers (CCBs), Beta-blockers, and Diuretics.
  • Combination Therapy: Most patients require two or more drugs to achieve targets.
  • Aspirin: Low-dose aspirin only when BP is controlled to avoid hemorrhagic stroke risk.

Clinical Drug Selection Guidance

• Thiazide Diuretics: Favored for isolated systolic hypertension in elderly, heart failure, and hypertension in Black patients.
• ACE Inhibitors: Favored for heart failure, post-MI, diabetic nephropathy, and LVH.
• Beta-blockers: Favored for angina pectoris, post-MI, heart failure, glaucoma, and pregnancy.
• Calcium Antagonists: Favored for angina, LVH, and pregnancy.
• Loop Diuretics: Indicated for end-stage renal disease and heart failure.

Hypertensive Emergencies and Urgencies

• Hypertensive Emergency: BP $> 180/110\,mmHg$ WITH evidence of acute target organ damage (e.g., papilledema, encephalopathy, MI, aortic dissection).
  • Treatment: IV Nitroprusside (malignant HTN/aortic dissection), IV Nitroglycerine (acute LV failure), IV Labetalol ($20-80\,mg$ bolus or $0.5-2.0\,mg/min$ infusion), Esmolol, or IV Enalaprilat.
• Hypertensive Urgency: High BP WITHOUT target organ damage.
  • Treatment: Rapid initiation of oral or IV treatment (Clonidine, CCBs, or Hydralazine $12-20\,mg$ IV/im).
• Resistant Hypertension: Failure to reach BP goal ($< 140/90\,mmHg$) despite using $3$ or more drugs (including a diuretic) for at least $3$ weeks.

Case Study: Clinical Inquiry

• Patient Profile: $52$-year-old housewife with $5$ children.
• Presentation: Repeated BP readings of $160/105\,mmHg$. Initially asymptomatic and refused medication.
• New Symptoms: Chest pain upon climbing $3$ floors, which disappears without medication.
• Work-up Requirements:
  • Diagnosis: Most likely Grade $2$ Hypertension with Stable Angina Pectoris.
  • History: Assess duration of HTN, family history, and detailed characterization of chest pain.
  • Investigations: Lipid profile, ECG, stress test (if appropriate), and renal function assessment.
  • Treatment Plan: Combine lifestyle modifications with pharmacological intervention (likely ACEI or Beta-blocker given the chest pain symptoms).